Clinical Trials Directory

Trials / Conditions / Relapsed or Refractory Multiple Myeloma (RRMM)

Relapsed or Refractory Multiple Myeloma (RRMM)

7 registered clinical trials studyying Relapsed or Refractory Multiple Myeloma (RRMM) — 6 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Phase 2, Single Arm Multicenter, Study Testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Partic
NCT07348393
Assistance Publique - Hôpitaux de ParisPhase 2
RecruitingDual-target BCMA-GPRC5D CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
NCT07003568
Beijing GoBroad HospitalPhase 1
RecruitingDual-target BCMA-CD19 CAR-T Cell Therapy for RR/MM With Extramedullary Infiltration
NCT07003555
Beijing GoBroad HospitalPhase 1
RecruitingIntravenous Autologous CD19 CAR-T Cells for R/ R MM, B-ALL, and B-Cell Lymphoma
NCT06961669
Anhui Provincial HospitalN/A
RecruitingA Study to Compare the Efficacy and Safety of BMS-986393 Versus Standard Regimens in Adult Participants With R
NCT06615479
Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyPhase 3
RecruitingPurinostat Mesylate Combined With Pomalidomide Capsules and Low-dose Dexamethasone in Patients With Relapsed o
NCT06484829
Chengdu Zenitar Biomedical Technology Co., LtdPhase 1 / Phase 2
TerminatedGEN3014 Trial in Relapsed or Refractory Hematologic Malignancies
NCT04824794
GenmabPhase 1 / Phase 2